推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

D Corti, J Voss, SJ Gamblin, G Codoni… - Science, 2011 - sciencemag.org
... 333 no. 6044 pp. 850-856 DOI: 10.1126/science.1205669. Research Article. A Neutralizing
Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A
Hemagglutinins. ... A neutralizing antibody selected in vivo for binding to group 1 and 2 HAs. ...
Cited by 1

The VD1 Neutralizing Antibody to Vascular Endothelial Growth Factor-D: Binding Epitope and Relationship to Receptor Binding

N Davydova, S Roufail, VA Streltsov… - Journal of Molecular …, 2011 - Elsevier
Vascular endothelial growth factor-D (VEGF-D) is a secreted protein that promotes tumor
growth and metastatic spread in animal models of cancer. Expression of VEGF-D in
prevalent human cancers was reported to correlate with lymph node metastasis and ...
All 2 versions

Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody

DR Burton, AJ Hessell, BF Keele… - Proceedings of the …, 2011 - National Acad Sciences
To guide vaccine design, we assessed whether human monoclonal antibodies (MAbs) b12 and
b6 against the CD4 binding site (CD4bs) on HIV-1 gp120 and F240 against an immundominant
epitope on gp41 could prevent vaginal transmission of simian HIV (SHIV)-162P4 to ...
Cited by 1 - Related articles - All 3 versions

LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays

[PDF] from biomedcentral.comB Piehler, E Nelson, J Eckels, S Ramsay… - BMC …, 2011 - biomedcentral.com
Britt Piehler (brittp@labkey.com) Elizabeth K Nelson (eknelson@labkey.com) Josh Eckels
(jeckels@labkey.com) Sarah Ramsay (sramsay@scharp.org) Karl Lum (klum@labkey.com) Blake
Wood (geebeewood@gmail.com) Kelli M Greene (kelli.greene@duke.edu) Hongmei Gao ...
Related articles - All 4 versions

A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

JE Ledgerwood, TC Pierson… - Journal of Infectious …, 2011 - jid.oxfordjournals.org
Methods. A DNA vaccine encoding the protein premembrane and the E glycoproteins of the NY99
strain of WNV under the transcriptional control of the CMV/R promoter was evaluated in an
open-label study in 30 healthy adults. Half of the subjects were age 18–50 years and half ...
Cited by 1 - Related articles - All 5 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451